维普中文期刊产品整合服务
280篇 您的检索式:作者名="Moran W"
    题名 作者 年代 出处 被引量
1Clinical predictors of thiopurine-related adverse events in Crohn's disease显示文摘AIM: To determine the incidence and predictors of thiopurine-related adverse events. METHODS: Subjects with Crohn's disease who were followed in the Alberta Inflammatory Bowel Disease Consortium patient database registry were identified. Retrospective chart review was conducted between August 5th, 2010 and June 1st, 2012. We collected data on: age at diagnosis; sex; disease location and behaviour at time of prescribing thiopurine; perianal fistulising disease at or prior to thiopurine prescription; smoking status at time of thiopurine prescription, use of corticosteroid within 6 mo of diagnosis; dosage, age at onset, and cessation of 5-aminosalicyclic acid(5-ASA); anti-tumour necrosis factor medication exposure and intestinal resection before thiopurine prescription. The primary outcome of interest was the first adverse event that led to discontinuation of the first thiopurine medication used. Logistic regression models were used to associate clinical characteristics with outcomes after adjusting for potential confounders. Risk estimates were presented as odds ratios(OR) with 95% CI. Effect modification by age and sex were explored.RESULTS: Our cohort had a median follow-up duration of 5.8 years [interquartile range(IQR 25th-75th) 2.7-9.1]. Thiopurine therapy was discontinued in 31.3% of patients because of: hypersensitivity reactions(7.1%), acute pancreatitis(6.2%), gastrointestinal intolerance(5.4%), leucopenia(3.7%), hepatotoxicity(3.4%), infection(1.1%) and other reasons(4.3%). A higher incidence of thiopurine withdrawal was observed in patients over the age of 40(39.4%, P = 0.007). A sexby-age interaction(P = 0.04) was observed. Females older than 40 years of age had an increased risk of thiopurine discontinuation due to an adverse event(age above 40 vs age below 40, adjusted OR = 2.8; 95%CI: 1.4-5.6). In contrast, age did not influence thiopurine withdrawal in males(age above 40 vs below 40, adjusted OR = 0.9; 95%CI: 0.4-2.1). Other clinical variables(disease location and phenotype, perianal disease, smoking history, history of intestinal resection and prior 5-ASA or corticosteroid use) were not associated with an increased risk an adverse event leading to therapy cessation. CONCLUSION: Thiopurine withdrawal due to adverse events is commoner in women over the age of 40 at prescription. These findings need to be replicated in other cohorts.Gordon W Moran Marie-France Dubeau Gilaad G Kaplan Hong Yang Bertus Eksteen Subrata Ghosh Remo Panaccione 2015World Journal of Gastroenterology2015,21,25:2
2Microcontact printing of catalytic nanoparticles for selective electroless deposition of metals on nonplanar polymeric substrates 显示文摘Ng W K Wu L Moran P M 2002Appl Phys Lett2002,81,16:1
3Residual stress measurement with focused acoustic waves and direct comparison with X-ray diffraction stress measurements显示文摘Moran Thomas J Martin Richard W Rveibel Richard 2005Materials Science and Engineering A2005,399,1:1
4Interaction of photochemical and microbial processes in the degradation of refractory dissolved organic matter from a coastal marine environment显示文摘Miller W J Moran M A 1997Limonl Oceanogr1997,42,:1
5Treatment of material discontinuity in the Element-Free Galerkin method显示文摘Cordes L W Moran B 1996Comput methods Appl Mech Engrg1996,139,:1
6A simple signal processing architecture for instantaneous radar polarimetry 显示文摘Howard S D Calderbank A R Moran W 2007IEEE Transactions on Information Theory2007,53,4:1
7Comparisons of male and female broiler responses to dietary threonine from 42 to 56 days of age显示文摘Dozier W A Moran Jr E T Kidd M T 2001J ApplPoult Res2001,10,:1
8Treatment of material discontinuity in the element-free Galerkin method显示文摘Cordes L W Moran B 1996Comput Meth Appl Mech Eng1996,139,:1
9Control System for Three Phase Active Power Filter which Simultaneously Compensates Power Factor and Unbalanced Loads显示文摘Dixon J W Garcia J J Moran L 1995Trans on Industrial Electronics1995,42,6:1
10Intensified CCD (ICCD) dynamic range and noise performance 显示文摘MORAN S E ULICH B L ELKINS W P SPIE0,3137,:1
11A Morphmetric Study of Human Lumbar and Selected Thoracic Vertebrae 显示文摘Berry J Moran J M Berg W S 1987Spine1987,12,4:1
12Primary intrapulmonary meniugiomas:a elinieopathologic and immu- nohistochemical study of ten cases 显示文摘MORAN CA HOCHHOLZER L RUSH W 1996Cancer1996,78,11:1
13Control system for three phase active power filter which simultaneously compensates power factor and unbalanced loads显示文摘Dixon J W Garcia J J Moran L 1995IEEE Trans on Industrial Electronics1995,42,6:1
14Patient personality and mortality: A 4-year prospective examination of chronic renal insufficiency显示文摘Christensen A J Ehlers S L Wiebe J S Moran P J Raichle K Ferneyhough K Lawton W J 2002Health Psychology2002,21,4:1
15Diagnosis and management of obstructive sleep apnea, a multidisciplinary approach 显示文摘 Moran W B 1985Arch Otolaryngol1985,111,9:1
16Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes显示文摘Moran A Palmas W Field L 2004Diabetes Care2004,27,4:1
17Photochemical release of biologically available nitrogen from aquatic dissolved organic matter显示文摘Bushaw K L Zepp R G Ta-r M A Schulz-Jander D Bourbonniere R A Hodson R E Miller W L Bronk D A Moran M A 2002Nature2002,381,:1
18A simple and low-cost control strategy for active power filters connected in cascade显示文摘MORAN L A FERNANDEZ L DIXON J W 1997IEEE Trans Ind Electron1997,44,5:1
19Treatment of material discontinuity in the element-free Galerkin method显示文摘Cordes L W Moran B 1996Computational Methods of Applied Mechnics and Engineering1996,139,:1
20Dissolved organic fluorophores in southeastern US coastal waters: correction method for eliminating Rayleigh and Raman scattering peaks in excitation- emission matrices显示文摘Zepp R G Sheldon W M Moran M A 2004Marine Chemistry2004,89,14:1
返回顶部 每页显示:
共14页 首页 上一页 第1页 下一页 末页 /14 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费